A Multicenter Phase II Study Of BMS 247550 [ixabepilone] (Epothilone B Analogue) In Indolent Lymphoproliferative Disorders
Latest Information Update: 03 Nov 2021
Price :
$35 *
At a glance
- Drugs Ixabepilone (Primary)
- Indications Lymphoproliferative disorders
- Focus Therapeutic Use
- 03 Jul 2007 Status changed from in progress to completed.
- 05 Sep 2005 New trial record.